<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04533269</url>
  </required_header>
  <id_info>
    <org_study_id>CI-B001</org_study_id>
    <nct_id>NCT04533269</nct_id>
  </id_info>
  <brief_title>A Study of Topical Arnica &amp; Ledum on Bruise Reduction in HNV</brief_title>
  <official_title>A Randomized, Double-Blind, Placebo-Controlled, Crossover Study of Arnica Montana and Ledum Palustre Formulation on Mechanically Induced Bruising in Healthy Normal Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cearna, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cearna, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Subjects will have a bruise induced. A pad containing either a placebo or active will be&#xD;
      applied to the bruise. Photographs will be taken over the following days to record bruise&#xD;
      healing.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized, double-blind, placebo-controlled, crossover, multicenter study that&#xD;
      will be used to evaluate the difference in bruise reduction efficacy between active remedy&#xD;
      and placebo when a mechanical bruise is induced. The trial will be conducted at 5-8 sites&#xD;
      with up to 150 subjects. Each subject will be injured two times using the same&#xD;
      bruise-inducing mechanism, and the resulting bruises will be treated with active remedy or&#xD;
      placebo-infused pads that will be identical in appearance. Subjects and study investigators&#xD;
      will be blinded to the order of treatment assignment. Subjects will be asked to come to the&#xD;
      clinic for photographic assessments of the bruise. Each subject will be randomly assigned to&#xD;
      have a placebo or active remedy pad applied over each mechanically induced bruise on Day 1.&#xD;
      The pad will be applied by study staff immediately after bruise induction (within 5 minutes).&#xD;
      The pad will cover the bruised area completely, and then sealed with Tegaderm. All&#xD;
      procedures, including bruise induction, treatment, and photography, will be administered by&#xD;
      study staff who are blinded to treatment type. All photographs will be rated according to&#xD;
      standardized criteria by blinded, trained study investigators after the completion of all&#xD;
      subject data collection.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 31, 2021</start_date>
  <completion_date type="Anticipated">November 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Treatment kits will be coded. An unblinded statistician will provide the treatment codes after the study database is locked.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy</measure>
    <time_frame>11 days</time_frame>
    <description>Time to bruise healing in active vs. placebo</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Bruise, Contusion</condition>
  <arm_group>
    <arm_group_label>Active</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Arnica montana and Ledum palustre infused Pad</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Pad (Matching appearance with Active)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Arnica montana, Ledum palustre</intervention_name>
    <description>Homeopathic</description>
    <arm_group_label>Active</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Fitzpatrick skin type 1-3&#xD;
&#xD;
          -  BMI 25 kg/m2&#xD;
&#xD;
          -  Self described bruisers&#xD;
&#xD;
          -  Intact skin in the target area, free of markings, blemishes and hair&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Use of recreational drugs, steroids, pain medications, other homeopathic remedies,&#xD;
             anticoagulant therapies, antiplatelet therapy&#xD;
&#xD;
          -  Known history of dermal sensitivity, serious illness, hematological abnormality,&#xD;
             impaired wound healing&#xD;
&#xD;
          -  Inability to forego application of topical products in the target area&#xD;
&#xD;
          -  Hair removal by laser, wax or chemicals within one week prior to Day 1&#xD;
&#xD;
          -  Avoid tanning beds&#xD;
&#xD;
          -  History of allergy to topical gels, Arnica or Ledum&#xD;
&#xD;
          -  Active wound or infection in the target area&#xD;
&#xD;
          -  History of keloids or hypertrophic scarring&#xD;
&#xD;
          -  History of collagen or vascular disease&#xD;
&#xD;
          -  History of organ transplant&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jacqueline Blem</last_name>
    <phone>858-945-6456</phone>
    <email>jacqui@cardiffclinical.com</email>
  </overall_contact>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>August 24, 2020</study_first_submitted>
  <study_first_submitted_qc>August 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 31, 2020</study_first_posted>
  <last_update_submitted>January 6, 2021</last_update_submitted>
  <last_update_submitted_qc>January 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Contusions</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Aggregate data will be shared and published.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

